Necrotic Enteritis Treatment Market Overview
Global necrotic enteritis treatment market is anticipated to be valued at US$ 25 Billion in 2022, forecast to grow at a CAGR of 7.18% during 2022-2032, to be valued at US$ 50 Billion by 2032.
Necrotic enteritis, also known as necrotizing enterocolitis, is an inflammatory bowel disease that affects prematurely born babies. Premature infants are those who are born before 37 weeks of pregnancy. According to the World Health Organization (WHO), approximately 15 million premature babies are born worldwide each year, with the number steadily increasing, and approximately 1 million babies die as a result of this condition.
India has the highest number of preterm births, followed by China, Nigeria, Pakistan, Indonesia, the United States, Bangladesh, the Philippines, Congo, and Brazil. Although the causes of necrotic enteritis are unknown, in December 2018, researchers at Johns Hopkins University School of Medicine discovered the molecular cause of the condition, which is likely to be related to brain injury. Necrotic enteritis is more likely to occur in prematurely born infants who have been infected. Necrotic enteritis affects 10–12% of prematurely born infants and the majority of cases result in death.
Get a Sample PDF Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-8316
Which are Some Prominent Drivers Spearheading Necrotic Enteritis Treatment Market Growth?
The rising prevalence of preterm births in both developed and developing countries remains a major market driving factor in the necrotic enteritis treatment market. Increased access to good healthcare, increased awareness, and medical attention to pregnancy-related complications all contribute to an increase in treatment-seeking, which drives the growth of the necrotic enteritis treatment market.
The necrotic enteritis treatment market is heavily influenced by ongoing research to identify a causative factor, and breakthrough results may significantly increase revenue generation in the near future. Increased funding for research and development in the necrotic enteritis treatment market by probiotic manufacturing companies is expected to fuel market growth.
What are the Challenges Faced by the Necrotic Enteritis Treatment Industry?
The time-consuming nature of developing new breakthrough treatments may impede the growth of the necrotic enteritis treatment market. The unknown cause of necrotic enteritis further limits treatment options, which are frequently ineffective, limiting necrotic enteritis treatment revenue generation.
Ask to Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-8316
Why is Asia-Pacific emerging as an Opportunistic Necrotic Enteritis Treatment Market?
Because of the high prevalence of preterm births in the region, Asia-Pacific is expected to be the second most lucrative necrotic enteritis treatment market. India and China are among the countries with the highest number of preterm births per year, which can have a significant impact on the necrotic enteritis treatment market.
Although the incidence of preterm birth is higher in the APAC region, a low rate of treatment seeking and product adoption limit the potential revenue generation of the necrotic enteritis treatment market.
Market Competition
Prometic Life Sciences Inc., BioGaia Probiotics, Fresenius Kabi AG, Actavis Plc. Bayer International, Alcon Laboratories, Inc., Bausch & Lomb Incorporated, GlaxoSmithKline plc. and Others are the key players in the global necrotic enteritis treatment market.
Attributed to the presence of such high number of participants, the market is highly competitive.
Buy this Report Now: https://www.futuremarketinsights.com/checkout/8316
Key Segments Profiled in the Necrotic Enteritis Treatment Industry Survey
By Drug Class:
- Necrotic Enteritis Treatment through Inter-Alpha-Inhibitor-Proteins (“IaIp”)
- Necrotic Enteritis Treatment through Antibiotics
- Necrotic Enteritis Treatment through Dietary Supplements
By Distribution Channel:
- Necrotic Enteritis Treatment Sales via Hospital Pharmacies
- Necrotic Enteritis Treatment Sales via Retail Pharmacies
- Necrotic Enteritis Treatment Sales via Online Pharmacies
- Necrotic Enteritis Treatment Sales via Drug Stores
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific
- Japan
- Middle East & Africa
About FMI:
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!
Contact Us:
Future Market Insights,
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs